Gonadotropin therapy versus laparoscopic ovarian drilling in clomiphene citrate-resistant polycystic ovary syndrome patients: A retrospective cost-effectiveness analysis

Gynecologic and Obstetric Investigation

Volumn 80, Issue 3, 2015, Pages 164-169

  De Frène, Veerle ^a   Gerris, Jan ^a   Weyers, Steven ^a   Dhont, Marc ^a   Vansteelandt, Stijn ^b   Annemans, Lieven ^b   De Sutter, Petra ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Clomiphene citrate resistance; Gonadotropin; Health economic evaluation; Ovarian drilling; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; HUMAN MENOPAUSAL GONADOTROPIN; CLOMIFENE; FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC EVALUATION; FEMALE; HUMAN; LAPAROSCOPIC OVARIAN DRILLING; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY; ANOVULATION; COST BENEFIT ANALYSIS; ECONOMICS; INFERTILITY, FEMALE; LAPAROSCOPY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; TREATMENT FAILURE; YOUNG ADULT;

ADULT; ANOVULATION; CLOMIPHENE; COST-BENEFIT ANALYSIS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; MENOTROPINS; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; YOUNG ADULT;

EID: 84946498361     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000373888     Document Type: Article

References (28)

1. Balen AH, Conway GS, Homburg R, Legro RS: Polycystic Ovary Syndrome. A Guide to Clinical Management, ed 1. London, Taylor and Francis, 2005.
2. The Thessaloniki ESHRE/ASRM-sponsored PCOS Consensus Workshop Group: Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89: 505-522.
3. Hara S, Takahashi T, Amita M, Igarashi H, Kurachi H: Usefulness of bezafibrate for ovulation induction in clomiphene citrate-resistant polycystic ovary syndrome patients with dyslipidemia: a prospective pilot study of seven cases. Gynecol Obstet Invest 2010; 70: 166-172.
4. Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R: Gonadotropin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2000;CD000410.
5. Farquhar C, Williamson K, Gudex G, Johnson NP, Garland J, Sadler L: A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril 2002; 78: 404-411.
6. Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F: Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ 2004; 328: 192.
7. Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P: Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2005;CD001122.
8. Farquhar C, Williamson K, Brown P, Garland J: An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod 2004; 19: 1110-1115.
9. van Wely M, Bayram N, van der Veen F, Bossuyt PMM: An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 2004; 19: 1741-1745.
10. Nahuis MJ, Oude Lohuis E, Kose N, Bayram N, Hompes P, Oosterhuis GJE, et al: Longterm follow-up of laparoscopic electrocautery of the ovaries versus ovulation induction with recombinant FSH in clomiphene citrate-resistant women with polycystic ovary syndrome: an economic evaluation. Hum Reprod 2012; 27: 3577-3582.
11. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
12. Absenteisme in Belgie 2006: Kosten, cijfers en medische redenen. Securex.
13. Steunpunt tot bestrijding van armoede, bestaansonzekerheid en sociale uitsluiting.
14. Gerris J, De Sutter P, De Neubourg D, Van Royen E, Vander Elst J, Mangelschots K, et al: A real-life prospective health economic study of elective single embryo transfer versus twoembryo transfer in first IVF/ICSI cycles. Hum Reprod 2004; 19: 917-923.
15. Hesterberg T, Moore DS, Monaghan S, Clipson A, Epstein R: Bootstrap methods and permutation tests; in Moore DS, McCabe GP, Craig BA (eds): Introduction to the Practice of Statistics, ed 6. New York, WH Freeman and Company, 2009, p 16-1-16-59.
16. World Health Organization: BMI classification. Geneva, World Health Organization, 2006.
17. Tsuji I, Ami K, Miyazaki A, Huijnami N, Hoshiai H: Benefit of diagnostic laparoscopy for patients with unexplained infertility and normal hysterosalpingography findings. Tohoku J Exp Med 2009; 219: 39-42.
18. Gordts S, Gordts S, Puttemans P, Valkenburg M, Campo R, Brosens I: Transvaginal hydrolaparoscopy in the treatment of polycystic ovary syndrome. Fertil Steril 2009; 91: 2520-2526.
19. Fernandez H, Alby J-D, Gervaise A, de Tayrac R, Frydman R: Operative transvaginal hydrolaparoscopy for treatment of polycystic ovary syndrome: a new minimally invasive surgery. Fertil Steril 2001; 75: 607-611.
20. Shibahara H, Hirano Y, Kikuchi K, Suzuki T, Takamizawa S: Postoperative endocrine alterations and clinical outcome of infertile women with polycystic ovary syndrome after transvaginal hydrolaparoscopic ovarian drilling. Fertil Steril 2006; 85: 244-246.
21. Catenacci M, Goldberg JM: Transvaginal hydrolaparoscopy. Semin Reprod Med 2011; 29: 95-100.
22. Lukassen HG, Schonbeck Y, Adang EM, Braat DD, Zielhuis GA, Kremer JA: Cost analysis of singleton versus twin pregnancies after in vitro fertilization. Fertil Steril 2004; 81: 1240-1246.
23. Nahuis MJ, Kose N, Bayram N, van Dessel HJ, Braat DD, Hamilton CJ, et al: Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Hum Reprod 2011; 26: 1899-1904.
24. Annemans L: Gezondheidseconomie voor niet- economen. Een inleiding tot de begrippen, methoden en valkuilen van de gezondheidseconomische evaluatie, ed 1. Gent, Academia Press, 2007.
25. Annemans L, Aristides M, Kubin M: Real-life data: a growing need. ISPOR Connections 2007; 13: 8-12.
26. Vrbikova J, Hainer V: Obesity and polycystic ovary syndrome. Obes Facts 2009; 2: 26-35.
27. Amer SAK, Gopalan V, Li TC, Ledger WL, Cooke ID: Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome. Hum Reprod 2002; 17: 2035-2042.
28. Drummond MF, Sculpher MJ, Torrance GW, OBrien BJ, Stoddard GL: Methods for the Economic Evaluation of Health Care Programmes, ed 3. New York, Oxford University Press, 2005.